David Illingworth, Smith & Nephew CEO, attributed the company’s profit increase to strong growth in the endoscopy and advanced wound management business. Additionally, the U.S. trauma and European orthopedic businesses also showed significant growth.
Smith & Nephew reported $137 million net profit for the second quarter of 2010, up from $118 million reported for the second quarter of 2009, and $226 million in trading profit.
Trading cash flow is reported as $202 million, an increase from last year’s second quarter report, partly attributed to focusing on tighter inventory management.
Read the release on Smith & Nephew 2Q FY 2010 report.
Read other coverage on Smith & Nephew:
– Smith & Nephew Reports 9% Increase in Q1 Revenues
– Data Reinforces Safety, Effectiveness of BIRMINGHAM HIP Resurfacing System
– Smith & Nephew Receives 501k Clearance to Claim 30-Year Performance With VERILAST Technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
